Delivery systems for hormone replacement therapy

Expert Opinion on Drug Delivery
Ian S Fraser, Diana Mansour

Abstract

The steroid hormones used for hormone replacement therapy in the menopausal transition and postmenopause can be administered by several different routes using a variety of delivery systems. The conventional approach to administration has been oral, and this is still the standard against which other routes are compared. However, there is a steadily increasing research development and popularity for alternative systems. Such systems can be geared to ultra low-dose delivery for local vaginal effect or higher dosages for systemic effect. Different delivery systems have a range of attributes with varying appeal to different individual women. Such a range of choices can be important for acceptability and compliance. One of the most important attributes of many newer delivery systems is the potential to deliver hormones in a controlled manner over prolonged periods of time, allowing constant low dosages, as well as constant blood and tissue levels. They also have the potential for reducing side effects and metabolic effects. Transdermal, subdermal, intravaginal and intrauterine systems are particularly likely to undergo refinement and further development in the foreseeable future with subsequent increases in popularity.

References

May 1, 1992·The American Journal of Clinical Nutrition·C J LeyJ C Stevenson
Feb 17, 1990·BMJ : British Medical Journal·K F GangarM P Cust
Sep 7, 1989·The New England Journal of Medicine·K A MatthewsR R Wing
May 1, 1987·American Journal of Obstetrics and Gynecology·W H Utian
Feb 1, 1986·Contraception·T LuukkainenJ Toivonen
Dec 1, 1987·The Journal of Clinical Endocrinology and Metabolism·S J RichardsonJ F Nelson
Feb 1, 1986·Journal of Pharmaceutical Sciences·J PithaM E Michel
Sep 1, 1995·American Journal of Obstetrics and Gynecology·S F Gordon
Jan 1, 1995·American Journal of Obstetrics and Gynecology·T H RaudaskoskiT J Laatikainen
Feb 1, 1995·American Journal of Obstetrics and Gynecology·S P SuhonenP Lähteenmäki
Mar 1, 1993·American Journal of Obstetrics and Gynecology·A OldenhaveW T Everaerd
Jan 4, 1993·Atherosclerosis·J C StevensonI F Godsland
Apr 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J P Marty
Oct 1, 1996·British Journal of Obstetrics and Gynaecology·M PorterA Templeton
Jan 1, 1997·British Journal of Obstetrics and Gynaecology·D H BarlowD W Sturdee
Jan 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R BarentsenJ H Schram
Dec 9, 1997·British Journal of Obstetrics and Gynaecology·E HirvonenG Wilén-Rosenqvist
May 16, 1998·American Journal of Epidemiology·H BurgerH A Pols
Dec 22, 1999·American Journal of Obstetrics and Gynecology·H A NashT M Harmon
Feb 8, 2000·Maturitas·J C Stevenson
May 16, 2000·Menopause : the Journal of the North American Menopause Society·J E RiouxD S Hepburn
Dec 21, 2000·Current Oncology Reports·T R TennantW M Stadler
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·F E Riphagen
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Feb 4, 2003·Expert Opinion on Pharmacotherapy·Gabrielle Dezarnaulds, Ian S Fraser
May 3, 2003·Climacteric : the Journal of the International Menopause Society·J E DewJ A Eden

❮ Previous
Next ❯

Citations

Jul 1, 2014·Menopause : the Journal of the North American Menopause Society·Jennifer CorbelliRachel Hess
Oct 31, 2008·Menopause : the Journal of the North American Menopause Society·Richard E HedrickLawrence J Lambrecht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Reviews in Therapeutic Drug Carrier Systems
A D WoolfsonR Gallagher
Journal of Pharmaceutical Sciences
M E JohnsonR Langer
© 2021 Meta ULC. All rights reserved